Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 41Other solid neoplasm 41Gynecologic 7Gastrointestinal 7Breast 6Lymphoid 2Head & Neck 2Genitourinary 2Sarcoma 1NET 1Endocrine 1Dermatologic 1

Conditions

Neuroendocrine Tumors 71Carcinoma, Neuroendocrine 8Gastro-enteropancreatic neuroendocrine tumor 6Carcinoid Tumor 6Neoplasm Metastasis 5Sarcoma 3Paraganglioma 3Pancreatic Neoplasms 3Carcinoma, Hepatocellular 3Adenoma, Islet Cell 3Thyroid Neoplasms 2Stomach Neoplasms 2Neoplasms 2Lung Neoplasms 2Turcot syndrome 1Triple Negative Breast Neoplasms 1Tertiary Lymphoid Structures 1Teratoma 1Small Intestinal Neuroendocrine Tumor 1Small Cell Lung Carcinoma 1Rectal Neuroendocrine Tumor 1Prostatic Neoplasms 1Pheochromocytoma 1Parkinson Disease 1Pancreatic Neuroendocrine Tumors in MEN1 1Osteomalacia 1Neuroendocrine Tumors With Metastasis 1Neuroendocrine Tumors Metastatic to the Liver 1Neuroendocrine Tumor Grade 3 1Neuroblastoma 1

Interventions

regorafenib 1Clinical Trials, Phase II as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Mesothelioma, Malignant × NET × Clear all
NCT03475953 2023-03-03

REGOMUNE

Institut Bergonié

Phase 1/2 Unknown
747 enrolled
BreastEndocrineGastrointestinalGenitourinaryHead & NeckNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Turcot syndrome, Tertiary Lymphoid Structures, Mesothelioma, Malignant, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡